Sun Pharma's market share of therapy drugs India 2022

Published by A. Minhas, Feb 13, 2024
In February 2022, Sun pharmaceuticals India saw a jump in its cardiac drug formulation Rosuvas, with a market share of over seven percent. This was followed by the pain and analgesics drug, Volini, at seven percent in that time period.

Market share of leading therapy drugs from Sun Pharmaceutical Industries Limited across India in February 2022

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

March 2022

Region

India

Survey time period

February 2022

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Pharmaceutical industry in India "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Pharmaceutical industry in India

Global overview

5

Market overview

5

Trade

5

Investment and deals

4

Key players

5

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical market in the PhilippinesInsurance industry in the PhilippinesDemographics of the PhilippinesCoronavirus (COVID-19) pandemic in the PhilippinesHealthcare in the Philippines
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.